Diabetic Foot Ulcer Market: Increasing Prevalence of Diabetes and Related Chronic Wounds

The diabetic foot ulcer market is expected to reach US$ 7,793.83 million by 2028 from US$ 4,279.65 million in 2020; it is estimated to grow at a CAGR of 7.9% from 2021 to 2028.

Diabetic foot ulcer is a frequent complication in diabetic patients, and it may lead to leg amputation. Diabetes patients, who rely on insulin as a part of diabetes therapy, are at a higher risk of developing a foot ulcer. Diabetic foot ulcers can also affect patients who have diabetes-related kidney, skin, or heart disease, as well as obesity. Also, people who consume alcohol have a higher risk of developing the diabetic foot ulcer. The growth of the diabetic foot ulcer market is attributed to the factors such as the increasing prevalence of diabetes and related chronic wounds and rising geriatric population. However, the high cost of advanced wound care treatments hinders the market growth. 

Request for sample at: https://www.theinsightpartners.com/sample/TIPRE00022321/

Key Findings from The Diabetic Foot Ulcer Market

By type, the diabetic foot ulcer market is segmented into advanced wound care dressings, biologics, and therapy device. In 2020, the advanced wound care dressings segment held the largest share of the market.

However, the biologics segment is estimated to register the highest CAGR during the forecast period owing to the factors such as growing research and development activities and surging new products launches for diabetic foot ulcer treatment.

The diabetic foot ulcer treatment market, by ulcer type, is segmented into neuropathic ulcers, ischemic ulcers, and neuro-ischemic ulcers. In 2020, the neuropathic ulcers segment held the largest share of the market, and the market for the same segment is expected to grow at the fastest rate in the coming years.

Based on end user, the diabetic foot ulcer treatment market is segmented into ambulatory surgical centers, hospitals, and home care. In 2020, the hospitals segment held the largest share of the market. Also, the market for the same segment is expected to grow at the fastest rate in the coming years owing to the availability of diabetologist, plastic surgeon, and other respective professionals in hospitals who take care of diabetic foot patients.

ConvaTec Inc; 3M Company (Acelity L.P. Inc.); Coloplast A/S; Smith & Nephew plc; B. Braun Melsungen AG; Medline Industries, Inc; Cardinal Health Inc; Organogenesis Holdings Inc; Mölnlycke Health Care; MiMedx Group, Inc; Kerecis hf; and URGO are among the leading companies operating in the diabetic foot ulcer market.

Increasing Prevalence of Diabetes and Related Chronic Wounds

Depending on time taken to heal, wounds can be classified as acute and chronic. Diabetes has emerged as one of the most impactful health emergencies of the world in the 21st century. As per the National Diabetes Statistics Report 2020, ~34.2 million people in the US have diabetes, and the diabetic population accounts for ~10.5% of the overall US population. According to the International Diabetes Federation (IDF), the number of people with diabetes in North America was ~46 million in 2017, and it is expected to reach 62 million by 2045, with the disease prevalence of ~35% during 2018–2045. Diabetes affects many parts of the body, particularly the feet. Diabetic foot ulcers are sores developed on feet; they can also develop from seemingly trivial injuries to the feet. Diabetic foot ulcers are the common causes of amputation due to diabetes. According to a report published in the International Journal of Endocrinology in 2017, ~15–25% of patients with diabetes are susceptible to foot ulcers during their lifetime. The risk of developing diabetic foot ulcers in patients diagnosed with diabetes is anticipated to be ~2%; however, in patients with a previous history of foot ulceration, this risk is expected to increase to 17–60% over the next three years. ~20% of hospital admissions in people with diabetes are because of foot ulcers.

As there are continuous occurrences of injuries caused due to diabetes in low- and medium-income, and high-income countries, the demand for diabetic foot ulcer treatments is on rise.

Place an Order Now: https://www.theinsightpartners.com/buy/TIPRE00022321/

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

We are committed to provide highest quality research and consulting services to our customers. We help our clients understand the key market trends, identify opportunities, and make informed decisions with our market research offerings at an affordable cost.

Contact Us

Contact Person: Sameer Joshi

Phone: +1-646-491-9876

Email- sales@theinsightpartners

Back to news